Wells Fargo Thoughts on Teva Pharma's (TEVA) NuvaRing Launch

January 15, 2021 8:25 AM EST Send to a Friend
Wells Fargo analyst David Maris reiterated an Equal Weight rating on Teva Pharma (NYSE: TEVA) Teva Pharmaceuticals (TEVA) disclosed that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login